Know Cancer

forgot password

Blackberry Intake and Biomarkers of Cancer Risk

40 Years
75 Years
Not Enrolling
Healthy Volunteers

Thank you

Trial Information

Blackberry Intake and Biomarkers of Cancer Risk

Inclusion Criteria:

- Non-smoking men and women

- Aged 40-75

- BMI 19-38 kg/m2

Exclusion Criteria:

- Younger then 40 ears old or older than 75 years old

- BMI less than 19 or greater than 38

- Use of blood-thinning medications such as warfarin, dicumarol, or anisinidione

- Presence of kidney disease, liver disease, gout, certain cancers, untreated thyroid,
gastrointestinal, other metabolic diseases or malabsorption syndromes

- Type 2 diabetes requiring the use of oral antidiabetic agents or insulin

- Fasting triglycerides greater than 300 mg/dL

- Fasting glucose greater than 126 mg/dL

- History of eating disorders or other dietary patterns which are not consistent with
the dietary intervention (e.g. vegetarians, very low fat diets, high protein diets)

- Use of prescription of over-the-counter antiobesity medications or supplements during
and for at least 6 months prior to the start of the study or a history of a surgical
intervention for obesity

- Active cardiovascular disease

- Use of any tobacco products in the past 6 months

- Use of oral or IV antibiotics during the month preceding the study or during the

- Unwillingness to abstain from vitamin, mineral, and herbal supplements for two weeks
prior to the start of the study

- Known (self-reported) allergy or adverse reaction to blackberries or gelatin

- Unable or unwilling to give informed consent or communicate with study staff

- Self-report of alcohol or substance abuse within the past 12 months and/or current
acute treatment or rehabilitation program for these problems (long-term participation
in Alcoholics Anonymous is not an exclusion)

- Other medical, psychiatric, or behavioral factors that in the judgment of the
Principal Investigator may interfere with study participation or the ability to
follow the intervention protocol

Type of Study:


Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Outcome Measure:

Change from baseline in 8-oxo-dG levels after 5 days

Outcome Time Frame:

Day 5

Safety Issue:


Principal Investigator

Janet A Novotny, Ph.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

Beltsville Human Nutrition Research Center, USDA


United States: Institutional Review Board

Study ID:




Start Date:

January 2011

Completion Date:

April 2011

Related Keywords:

  • Healthy Volunteers



Beltsville Human Nutrition Research CenterBeltsville, Maryland  20705